Coronavirus Essential | Phase 3 trials for India's Covaxin to start next month; USFDA approves Remdesivir as the first COVID-19 treatment drug

Headliner Embed

Embed code See more options

Share

Facebook X

Subscribe

Tune in to Coronavirus Essential with Sakshi Batra for all the latest news on the pandemic.

Share

Facebook X

Subscribe

Next

Hot Stocks | Can bet on Bharat Forge, CEAT for short-term

Top episodes

The Market Podcast | Why Airtel rose despite AGR setback and what to do with DMart, Yes Bank and IRCTC

by Moneycontrol Podcast

Interview | Ramesh Damani's thumb rule of 24% returns can make you really rich

by Moneycontrol Podcast

Coronavirus Essential | PM Modi’s lights out, light up message; lockdown may continue until September, says study

by Moneycontrol Podcast

•   Report this episode
•   Download audio
•   QRCode